Y-mabs to participate at upcoming investor conferences in september

New york, sept. 06, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the company will participate at the following upcoming investor conferences:
YMAB Ratings Summary
YMAB Quant Ranking